Chevy Chase Trust Holdings, Inc. Novartis Ag Transaction History
Chevy Chase Trust Holdings, Inc.
- $31.1 Billion
- Q2 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 1,112,491 shares of NVS stock, worth $123 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
1,112,491
Previous 845,001
31.66%
Holding current value
$123 Million
Previous $81.7 Million
44.9%
% of portfolio
0.38%
Previous 0.27%
Shares
28 transactions
Others Institutions Holding NVS
# of Institutions
1,434Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.35 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.35 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$820 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$819 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$657 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $238B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...